Juventas Therapeutics
Cleveland, Ohio, United States
About Juventas Therapeutics
Juventas Therapeutics is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life’threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $48.7M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2015)
- Website: juventasinc.com
- Phone: (216)273-4000
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/juventas-therapeutics-2462998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.